MCID: PRS031
MIFTS: 17

Prostate Carcinoma in Situ

Categories: Cancer diseases, Reproductive diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Prostate Carcinoma in Situ

MalaCards integrated aliases for Prostate Carcinoma in Situ:

Name: Prostate Carcinoma in Situ 12 15
Carcinoma in Situ of Prostate 12 73
Grade Iii Pin 12
Pin Iii 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8634
ICD10 33 D07.5
ICD9CM 35 233.4
NCIt 50 C3642
SNOMED-CT 68 128640002 92691004
UMLS 73 C0154088

Summaries for Prostate Carcinoma in Situ

MalaCards based summary : Prostate Carcinoma in Situ, is also known as carcinoma in situ of prostate. An important gene associated with Prostate Carcinoma in Situ is LPP (LIM Domain Containing Preferred Translocation Partner In Lipoma). Affiliated tissues include prostate, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Related Diseases for Prostate Carcinoma in Situ

Symptoms & Phenotypes for Prostate Carcinoma in Situ

GenomeRNAi Phenotypes related to Prostate Carcinoma in Situ according to GeneCards Suite gene sharing:

26 (show all 17)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.6 ALDOA LPP
2 Increased shRNA abundance (Z-score > 2) GR00366-A-121 9.6 ALDOA
3 Increased shRNA abundance (Z-score > 2) GR00366-A-122 9.6 ALDOA
4 Increased shRNA abundance (Z-score > 2) GR00366-A-125 9.6 ALDOA
5 Increased shRNA abundance (Z-score > 2) GR00366-A-132 9.6 LPP
6 Increased shRNA abundance (Z-score > 2) GR00366-A-137 9.6 ALDOA
7 Increased shRNA abundance (Z-score > 2) GR00366-A-166 9.6 ALDOA
8 Increased shRNA abundance (Z-score > 2) GR00366-A-189 9.6 ALDOA
9 Increased shRNA abundance (Z-score > 2) GR00366-A-196 9.6 LPP
10 Increased shRNA abundance (Z-score > 2) GR00366-A-21 9.6 ALDOA
11 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.6 ALDOA LPP
12 Increased shRNA abundance (Z-score > 2) GR00366-A-54 9.6 LPP
13 Increased shRNA abundance (Z-score > 2) GR00366-A-73 9.6 LPP
14 Increased shRNA abundance (Z-score > 2) GR00366-A-76 9.6 LPP
15 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.6 ALDOA
16 Increased shRNA abundance (Z-score > 2) GR00366-A-88 9.6 LPP
17 Increased shRNA abundance (Z-score > 2) GR00366-A-96 9.6 LPP

Drugs & Therapeutics for Prostate Carcinoma in Situ

Search Clinical Trials , NIH Clinical Center for Prostate Carcinoma in Situ

Genetic Tests for Prostate Carcinoma in Situ

Anatomical Context for Prostate Carcinoma in Situ

MalaCards organs/tissues related to Prostate Carcinoma in Situ:

41
Prostate

Publications for Prostate Carcinoma in Situ

Variations for Prostate Carcinoma in Situ

Expression for Prostate Carcinoma in Situ

Search GEO for disease gene expression data for Prostate Carcinoma in Situ.

Pathways for Prostate Carcinoma in Situ

GO Terms for Prostate Carcinoma in Situ

Sources for Prostate Carcinoma in Situ

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....